Literature DB >> 11786148

Bovine pancreatic secretion in the first week of life: potential involvement of intestinal CCK receptors.

Romuald Zabielski1, Jean Morisset, Paweł Podgurniak, Véronique Romé, Marzena Biernat, Christine Bernard, Jean Alain Chayvialle, Paul Guilloteau.   

Abstract

The aim of this study was to evaluate pancreatic juice secretion of calves in the first postnatal days, and determine a potential involvement of cholecystokinin (CCK) and intestinal CCK receptor in its regulation. Nine neonatal Friesian calves (five controls and four treated intraduodenally with FK480, a CCK-A receptor antagonist) were surgically fitted with a pancreatic duct catheter and a duodenal cannula before the first colostrum feeding. Collections of pancreatic juice and duodenal luminal pressure recordings were started early after recovery from anaesthesia and continued for 6 days. From day 2 or 3 of life, periodic fluctuations in pancreatic secretions were observed in concert with duodenal myoelectric motor complex (MMC) and variations in plasma pancreatic polypeptide (PP) concentrations. Intraduodenal administration of FK480 reduced pancreatic juice secretion while intravenous infusion of CCK had no effect. Immunocytochemistry indicated an association of mucosal CCK-A and -B receptors with neural components of the small intestine. In conclusion, periodic activity of the exocrine pancreas exists in neonatal calves soon after birth and local neural intestinal CCK-A receptors could be partly responsible for the modulation of neonatal calf pancreatic secretion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786148     DOI: 10.1016/s0167-0115(01)00362-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  1 in total

1.  Bovine milk proteome in the first 9 days: protein interactions in maturation of the immune and digestive system of the newborn.

Authors:  Lina Zhang; Sjef Boeren; Jos A Hageman; Toon van Hooijdonk; Jacques Vervoort; Kasper Hettinga
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.